Study Stopped
Failure to enroll/recruit
Safety of Optimal PEEP in NSICU Patients
Evaluating Safety of Transpulmonary Pressure Guided PEEP Management in Neurocritical Care Patients
1 other identifier
interventional
1
1 country
1
Brief Summary
The investigators aim to demonstrate that use of transpulmonary pressure to guide PEEP management is safe in patients with possible elevations of intracranial pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2019
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 4, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 4, 2019
CompletedFirst Posted
Study publicly available on registry
March 5, 2019
CompletedResults Posted
Study results publicly available
April 1, 2021
CompletedApril 27, 2021
September 1, 2020
3 days
March 1, 2019
March 5, 2021
April 6, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in ICP Value
The Intracranial pressure (ICP) value after intervention will be considered equivalent to the ICP before intervention if the 95% upper bound of the change is lower than the non-inferiority margin of 4 mm Hg.
Within 5 minutes of catheter placement
Secondary Outcomes (2)
Change in Cerebral Perfusion Pressure (CPP)
Immediately before and 5 minutes after ventilator setting change
Change in Mean Arterial Pressure
Immediately before and 5 minutes after ventilator setting change
Study Arms (1)
Esophageal Balloon catheter
EXPERIMENTALAll patients will have an esophageal balloon catheter inserted into their nare while upright (head of bed \> 30 degrees) to a depth slightly more than the estimated distance from the lower sternum to the back of the ear (typically around 60 cm). Gastric positioning will be confirmed with abdominal compression testing and the catheter then retracted 10 - 20 cm into the lower esophagus. Placement will be confirmed with the presence of cardiac oscillations on the esophageal probe. The probe will then be secured to the patient's nasal opening using tape.
Interventions
Pressures \[Esophageal Pressure (Pes), Airway Pressure (Paw), and Transpulmonary Pressure (Ptp)\] are measured directly through the ventilator. The waveforms of Paw, Pes, and Ptp will be visualized on the ventilator. Ptp is obtained from Paw - Pes. All patients will have baseline measurements recorded of ICP, CPP, and MAP. PEEP will be increased on the ventilator to achieve a Ptp between 0 and +2 cm H2O ("Optimal PEEP"). Measurements of Intracranial pressure (ICP), cerebral perfusion pressure (CPP), and mean arterial pressure (MAP) will be repeated 5 minutes after the change in PEEP.
Eligibility Criteria
You may qualify if:
- Adult patients (age \>/= 18) admitted to the Neuro ICU of UNC Hospital requiring mechanical ventilation and with ICP monitoring in place.
You may not qualify if:
- Pneumothorax or pneumomediastinum
- Life expectancy \< 24 hours or expected to require mechanical ventilation for \< 24 hours
- Condition that precludes placement of an esophageal balloon \[esophageal or nasopharyngeal pathology preventing insertion of the esophageal balloon catheter (esophageal ulcerations, tumors, diverticulitis, bleeding varices or in patients with sinusitis, epistaxis or recent nasopharyngeal surgery), severe thrombocytopenia (platelet count \< 30) or coagulopathy (INR \> 3 or on oral anticoagulants).
- Pre-enrollment ICP \> 20 mm Hg
- Pre-enrollment CPP \< 60 mm Hg
- Planned change in the external ventricular drain set point during the pre-intervention, intervention or post-intervention periods
- Incarceration
- Variation in ICP of \> 2 cm H2O in the hour prior to intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Amanda Kovacich, MD
- Organization
- University of North Carolina at Chapel Hill
Study Officials
- PRINCIPAL INVESTIGATOR
Shannon Carson, MD
University of North Carolina, Chapel Hill
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2019
First Posted
March 5, 2019
Study Start
March 1, 2019
Primary Completion
March 4, 2019
Study Completion
March 4, 2019
Last Updated
April 27, 2021
Results First Posted
April 1, 2021
Record last verified: 2020-09